Abstract
The second messenger cGMP is a major intracellular mediator of the vaso-active agents nitric oxide and natriuretic peptides. The principal targets of cGMP are (i) phosphodiesterases, resulting in interference with the CAMP-signalling pathway, (ii) cGMPgated cation channels, and (iii) cGMP-dependent protein kinases (cGKs). Only two mammalian isotypes of cGK have been described so far: type I cGK, consisting of an α and a β isoform, presumably splice variants of a single gene, and identified as the most prominent cGK isotype in the cardio-vascular system; and type II cGK, expressed mainly in the intestine, the kidney and the brain. High levels of cGK I are found in vascular smooth muscle cells, endothelial cells and platelets. In these cells, cGK I is thought to counteract the increase in contraction provoked by Ca-mobilizing agonists, to reduce endothelial permeability and to inhibit platelet aggregation, respectively. Relatively low levels of cGK I are found in cardiomyocytes. In this cell type, cGK is implicated in the negative inotropic effect of cGMP, presumably through modulation of Ca channels and by diminishing the Ca-sensitivity of contractile proteins.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ashman DF, Lipton R, Melicow MM, Price T: Isolation of adenosine 3′, 5′-monophosphate and guanosine 3′, 5′-monophosphate from rat urine. Biochem Biophys Res Commun 11: 330–334, 1963
Arnold WP, Mittal CK, Katsuki S, Murad F: Nitric oxide activates guanylate cyclase and increases guanosine 3′, 5′-monophosphate levels in various tissue preparations. Proc Natl Acad Sci USA 74: 3203–3207, 1977
Field M., Graf LH jr, Laird WJ, Smith PL: Heat-stable enterotoxin of Escherichia coli: In vitro effects on guanylate cyclase activity, cyclic GMP concentration and ion transport. Proc Natl Acad Sci USA 75: 2800–2804, 1978
Murad F (ed): Cyclic GMP: synthesis, metabolism, and function. Adv Pharmacol 26: 1–330, 1994
Schmidt HHHW, Lohmann SM, Walter U: The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim Biophys Acta 1178: 153–175, 1993
Currie MG, Geller D, Cole BR, Boylan JC, YuSheng W, Holmberg SW, Needleman P: Bioactive cardiac substances: potent vasorelaxant activity in mammalian atria. Science 221: 71–73, 1983
Flynn TG, deBold ML, deBold AJ: The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties. Biochem Biophys Res Commun 117: 859–865, 1983
Benner BM, Ballermann BJ, Gunning ME, Zeidel ML: Diverse biological actions of atrial natriuretic peptide. Physiol Rev 70: 665–699, 1990
Drewett JG, Garbers DL: The family of guanylyl cyclase receptors and their ligands. Endocrine Rev 15: 135–162, 1994
Sudoh T, Kangawa K, Minamino N, Matsuo H: A new natriuretic peptide in porcine brain. Nature 332: 78–81, 1988
Sudoh T, Minamino N, Kangawa K, Matsuo H: C-type natriuretic peptide (CNP): A new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 168: 863–870, 1990
Fuller F, Porter JG, Arfsten AE, Miller J, Schilling JW, Scarborough RM, Lewicki JA, Schenk DB: Atrial natriuretic peptide clearance receptor: Complete sequence and functional expression of cDNA clones. J Biol Chem 263: 9395–9401, 1988
Currie MG, Fok KF, Kato J, Moore RJ, Hamra FK, Duffin KL, Smith CE: Guanylin: An endogenous activator of intestinal guanylate cyclase. Proc Natl Acad Sci USA 89: 947–951, 1992
Forte LR, Currie MG: Guanylin: a peptide regulator of epithelial transport. FASEB J 9: 643–650, 1995
Palmer RMJ, Ferrige, AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524–526, 1987
Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chadhuri G: Endothelium-derived relaxing factor produced and secreted from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84: 9265–9269, 1987
Schmidt HHHM, Walter U: NO at work. Cell 78: 919–925, 1994
Petros A, Bennet D, Vallance P: Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338: 1557–1558, 1991
Wei XQ, Charles IG, Smith A, Ure J, Feng GJ, Huang FP, Damo X, Muller W, Moncada S, Liew FY: Altered immune response in mice lacking inducible nitric oxide synthase. Nature 375: 408–411, 1995
Christodoulides N, Durante W, Kroll MH, Schafer AJ: Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide. Circulation 91: 2306–2309, 1995
Garbers DL, Lowe DG: Guanylyl cyclase receptors. J Biol Chem 269: 30741–30744, 1994
Vaandrager AB, van der Wiel E, Hom ML, Luthjens, LH, De Jonge HR: Heat-stable enterotoxin receptor/guanylyl cyclase C is an oligomer consisting of functionally distinct subunits, which are non-covalently linked in the intestine. J Biol Chem 269: 16409–16415, 1994
Fulle HJ, Vassar R, Foster DC, Yang RB, Axel R, Garbers, DL: A receptor guanylyl cyclase expressed specifically in olfactory sensory neurons. Proc Natl Acad Sci USA 92: 3571–3575, 1995
Drewett JG, Fendly BM, Garbers DL, Lowe DG: Natriuretic peptide receptor-B (guanylyl cyclase-B) mediates C-type natriuretic peptide relaxation of precontracted rat aorta. J Biol Chem 270: 4668–4674, 1995
Vaandrager AB, De Jonge HR: Effects of cGMP on intestinal transport. Adv Pharmacol 26: 253–283, 1994
Butt E, Geiger J, Jarchau T, Lohmann SM, Walter U: The cGMP-dependent protein kinase: Gene, protein and function. Neurochem Res 18: 27–42, 1993
Baron DA, Lofton CE, Newman WH, Currie MG: Atriopeptin inhibition of thrombin-mediated changes in the morphology and permeability of endothelial monolayers. Proc Natl Acad Sci USA 86: 3394–3398, 1989
Appel RG: Growth-regulatory properties of atrial natriuretic factor. Am J Physiol 262: F911-F918, 1992
Forte LR, Thorne PK, Eber SL, Krause WJ, Freeman RH, Francis SH, Corbin JD: Stimulation of intestinal C1 transport by heat-stable enterotoxin: Activation of CAMP-dependent protein kinase by cGMP. Am J Physiol 263: C607-C615, 1992
Lincoln TM, Komalavilas P, Cornwell TL: Pleiotropic regulation of vascular smooth muscle tone by cGMP-dependent protein kinase. Hypertension 23: 1141–1147, 1994
Lincoln TM, Cornwell TL, Taylor AE: cGMP-dependent protein kinase mediates the reduction of Ca by CAMP in vascular smooth muscle cells. Am J Physiol 258: C399-C407, 1990
Lincoln TM, Cornwell TL: Intracellular cyclic GMP receptor proteins. FASEB J 7: 328–338, 1993
Biel M, Zong X, Distler M, Bosse E, Klugbauer N, Murakami M, Flockerzi V, Hofmann: Another member of the cyclic nucleotide-gated channel family, expressed in testis, kidney and heart. Proc Natl Acad Sci USA 91: 3505–3509, 1994
Light DB, Corbin JD, Stanton BA: Dual ion-channel regulation by cyclic GMP and cyclic GMP-dependent protein kinase. Nature 344: 336–339, 1990
Hofmann F, Dostmann W, Keilbach A, Landgraf W, Ruth P: Structure and physiological role of cGMP-dependent protein kinase. Biochim Biophys Acta 1135: 51–60, 1992
Francis SH, Corbin JD: Structure and function of cyclic nucleotide-dependent protein kinases. Ann Rev Physiol 56: 237–272, 1994
Colbran JL, Francis SH, Leach AB, Thomas MK, Jiang H, McAllister LM, Corbin JD: A phenylalanine in peptide substrates provides for selectivity between cGMP-dependent and cAMP-dependent protein kinases. J Biol Chem 267: 9589–9594, 1992
Butt E, Abel K, Krieger, M, Palm D, Hoppe V, Hoppe J, Walter U: CAMP- and cGMP dependent protein kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in intact human platelets. J Biol Chem 269: 14509–14517, 1994
Butt E, Nolte C, Schulz S, Beltman J, Beavo JA, Jastorff B, Walter U: Analysis of the functional role of cGMP-dependent protein kinase in intact human platelets using a specific activator 8-para-chlorophenylthio-cGMP. Biochem Pharmacol 43: 2591–2600, 1992
Butt E, Eigenthaler M, Genieser HG: (Rp)-8-pCPT-cGMPS, a novel cGMP-dependent protein kinase inhibitor. Eur J Pharmacol 269: 265–268, 1994
Sandberg M, Natarajan V, Ronander I, Kalderon D, Walter U, Lohmann SM, Jahnsen T: Molecular cloning and predicted full-lengths aminoacid sequence of the type Iβ isozyme of cGMP-dependent protein kinase from human placenta. FEBS Lett 255: 321–329, 1989
Wernet W, Flockerzi V, Hofmann F: The cDNA of the two isoforms of bovine cGMP-dependent protein kinase. FEBS Lett 251: 191–196, 1989
Uhler M: Cloning and expression of a novel cyclic GMP-dependent protein kinase from mouse brain. J Biol Chem 268: 13586–1359, 1993
Jarchau T, Häusler C, Markert T, Pohler D, Vandekerckhove J, De Jonge HR, Lohmann SM, Walter U: Cloning, expression and in situ localization of rat intestinal cGMP-dependent protein kinase II. Proc Natl Acad Sci USA 91: 9426–9430, 1994
French PJ, Bijman J, Edixhoven M, Vaandrager AB, Scholte BJ, Lohmann SM, Nairn AC, De Jonge HR: isotype-specific activation of CFTR-chloride channels by cGMP-dependent protein kinase type II. J Biol Chem 270: 26626–26631, 1995
Tilly BC, Bezstarosti K, Boomaars WEM, Marino CR, Lamers JMJ, De Jonge HR: Expression and regulation of chloride channels in neonatal rat heart cardiomyocytes. Mol Cell Biochem, this volume, pp. 129–155
Dong Y-J, Chao AC, Kouyama K, Hsu Y-P, Bocian RC, Moss RB, Gardner P: Activation of CFTR chloride current by nitric oxide in human T lymphocytes. EMBO J 14: 2700–2707, 1995
Markert T, Vaandrager AB, Gambaryan S, Pöhler D, Häusler C, Walter U, De Jonge HR, Jarchau T, Lohmann SM: Endogenous expression of type II cGMP-dependent protein kinase mRNA and protein in rat intestine: Implications for cystic fibrosis transmembrane conductance regulator. J Clin Invest 96: 822–830, 1995
MacMillan-Crow LA, Lincoln TM: High-affinity binding and localization of the cyclic GMP-dependent protein kinase with the intermediate filament protein vimentin. Biochemistry 33: 8035–8043, 1994
De Jonge HR: Cyclic GMP-dependent protein kinase in intestinal brush borders. Adv Cyclic Nucleotide Res 14: 315–333, 1981
Draijer R, Vaandrager AB, Nolte C, De Jonge HR, Walter U, van Hinsbergh VWM: Expression and possible functional role of cGMP-dependent protein kinase and its substrate VASP in human endothelial cells of different origin. Circ Res 1995 77: 897–905, 1995
Mery P-F, Lohmann SM, Walter U, Fischmeister R: Ca current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc Natl Acad Sci USA 88: 1197–1201, 1991
Keilbach A, Ruth P, Hofmann F: Detection of cGMP-dependent protein kinase isozymes by specific antibodies. Eur J Biochem 208: 467–473, 1992
Somlyo AP, Somlyo AV: Signal transduction and regulation in smooth muscle. Nature 372: 231–236, 1994
Pfeifer A, Numberg B, Kamm S, Uhde M, Schultz G, Ruth P, Hofmann F: Cyclic GMP-dependent protein kinase blocks pertussis toxin-sensitive hormone receptor signaling pathways in chinese hamster ovary cells. J Biol Chem 270: 9052–9059, 1995
Alioua A, Huggins JP, Rousseau E: PKG-1a phosphorylates the a subunit and upregulates reconstituted GKCa channels from tracheal smooth muscle. Am J Physiol 268: L1057-L1063, 1995
White RE, Lee AB, Shcherbatko AD, Lincoln TM, Schonbrunn A, Armstrong DL: Potassium channel stimulation by natriuretic peptides through cGMP-dependent dephosphorylation. Nature 361: 263–266, 1993
Eigenthaler M, Ullrich H, Geiger J, Horstrup K, Hönig-Liedl P, Wiebecke D, Walter U: Defective nitrovasodilator-stimulated protein phosphorylation and calcium regulation in cGMP-dependent protein kinase-deficient human platelets of chronic myelocytic leukemia. J Biol Chem 268: 13526–13531, 1993
Haffner C, Jarchau T, Reinhard M, Hoppe J, Lohmann SM, Walter U: Molecular cloning, structural analysis and functional expression of the proline-rich focal adhesion and microfilament-associated protein VASP. EMBO J 14: 19–27, 1995
Reinhard M, Halbrügge M, Scheer U, Wiegand C, Jockusch BM, Walter U: The 46/50 kDa phosphoprotein VASP purified from human platelets is a novel protein associated with actin filaments and focal contacts. EMBO J 11: 2063–2070, 1992
Lum H, Malik AB: Regulation of vascular endothelial barrier function. Am J Physiol 267: L223-L241, 1994
Draijer R, Atsma DE, van der Laarse A, van Hinsbergh VWM: cGMP and nitric oxide modulate thrombin-induced endothelial permeability. Regulation via different pathways in human aortic and umbilical vein endothelial cells. Circ Res 76: 199–208, 1995
Cannell MB, Cheng H, Lederer WJ: The control of calcium release in heart muscle. Science 268: 1045–1049, 1995
Hartzell HC, and Fischmeister R: Direct regulation of cardiac Ca channels by G proteins: neither proven nor necessary? Trends Pharmacol Sci 13: 380–385, 1992
Shah AM, Spurgeon HA, Sollott SJ, Talo A, Lakatta EG: 8-Br-cGMP reduces the myofilament response to Ca in intact cardiac myocytes. Circ Res 74: 970–978, 1994
Takens-Kwak BR, Jongsma HJ: Cardiac gap junctions: three distinct single channel conductances and their modulation by phosphorylating treatments. Pflügers Arch 422: 198–200, 1992
Clemo HF, Feher JJ, Baumgarten CM: Modulation of rabbit ventricular cell volume and Na/K/2Cl cotransport by cGMP and atrial natriuretic factor. J Gen Physiol 100: 89–114, 1992
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vaandrager, A.B., de Jonge, H.R. Signalling by cGMP-dependent protein kinases. Mol Cell Biochem 157, 23–30 (1996). https://doi.org/10.1007/BF00227877
Issue Date:
DOI: https://doi.org/10.1007/BF00227877